Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS trial_result · 2014-12-15

Clinical Trial Update: Comparative Study of 3 Dose Regimens of BioChaperone to Becaplermin Gel for the Treatment of Diabetic Foot Ulcer [Phase 1, Phase 2]

View source ↗

Summary

A completed Phase 1/2 trial comparing three dose regimens of BioChaperone to Becaplermin Gel for the treatment of Diabetic Foot Ulcers.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • Becaplermin Gel (becaplermin)
  • BioChaperone

Snippet

Sponsor: Virchow Group | Conditions: Diabetic Foot Ulcers | Phase 1, Phase 2 | Status: COMPLETED